PEPTIDE BASED IMMUNE SYSTEM RESPONSE MODIFIERS

Brand Owner Address Description
PEPTIMER Peptimmune, Inc. 64 Sidney Street Cambridge MA 02139 peptide-based immune system response modifiers in prescription pharmaceutical compositions for the modulation of immune or autoimmune responses in the prophylaxis or treatment of conditions in the nature of insulin dependent, juvenile-onset diabetes, multiple sclerosis, pemphigus vulgaris, Grave's disease, myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, Hashimoto's thyroiditis, asthma, pathogenic infections, cancer, and allogeneic tissue graft rejection;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The disclosure provides methods for the treatment and prevention of periodontal disease. In preferred embodiments, the invention provides for local treatment of periodontal tissues with a pharmaceutical composition including an immune response modifier (IRM) selected from the group of immune response modifiers comprising imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphtyridine amines, oxazoloquinoline amines, thiazoloquinoline amines and 1,2-bridged imidazopyridine amines.